PBMI Report Shows Changes in Pharmacy Benefit Design to Meet Cost Challenges
PBMI Releases 2016 Trends in Drug Benefit Design Report
Plano, TX (Marketwired – December 12, 2016) ―Although employers continue to cite managing drug cost trend as the number one goal, they are addressing this challenge head on by implementing significant changes in drug benefit design. This is just a sampling of the results from PBMI’s 2016 Trends in Drug Benefit Design Report released today. The report includes responses from 337 benefit leaders representing employers with an estimated 12.3 million covered lives.
“As drug costs continue to rise, it’s no surprise that this year’s report shows employers maintain focusing their goals in the areas of managing specialty and overall drug benefit cost trend,” says Jane Lutz, Executive Director of PBMI. “As employers look to the future, collaboration to design more effective benefit designs is critical.”
The following are a few of the key findings from this year’s report:
- Employers are changing pharmacy benefit designs to manage cost increases
- Plans with four or more tiers continue to grow – 38% have four or more tiers, compared to only 26% in 2012
- Use of pharmacy deductibles are common and growing with 38% having a pharmacy deductible, either specific to the drug benefit or combined with the medial benefit
- Employers are also increasing use of incentives to encourage healthy behaviors
- Rewarding members who participate in health risk assessments increased by 12%
- Use of incentives to motivate behavior change rose 17%
- Reducing copayments for members who participate in care management programs increased 1%
- The report also identifies several opportunities
- 64% do not use preferred or limited retail networks
- 47% do not send member communications to encourage mail order or on-site pharmacy use
- Only 62% of employers reporting they currently have a program in place despite epidemic rates of substance abuse
“We hope our research continues to drive meaningful conversations and brings together all stakeholders involved in benefit design creation,” adds Lutz.
PBMI will host a free webinar on December 15 at 1:30 pm EST to showcase the report. Register today. To download or request a printed copy of this report click here.
About PBMI
The Pharmacy Benefit Management Institute provides research and education to help healthcare and benefits professionals work with pharmacy benefit managers to design prescription drug benefit programs. Learn more at www.pbmi.com.
Recent Posts
-
Senior Care Pharmacy Coalition Opposes CMS Final Rule on Minimum Staffing Standards for LTC Facilities
The Senior Care Pharmacy Coalition (SCPC), the leading national voice for the long-term care pharmacy sector, released a statement today regarding its opposition to the Centers for Medicare & Medicaid Services (CMS) final rule on minimum staffing standards for long-term care (LTC) facilities.
-
Senior Care Pharmacy Coalition Shares Comments with CMS Regarding Medicare Part D Restructuring Guidance: “Smoothing Provisions”
SCPC filed comments with CMS in response to their guidance on the implementation of the Medicare Part D restructuring portion of the Inflation Reduction Act (IRA).
-
Drug pricing efforts threaten ‘very existence’ of LTC pharmacies: reps
President Biden in his State of the Union address last week vowed to end “Big Pharma’s” grip on prescription drug pricing and cut costs for seniors and taxpayers by another $200 million.
But the president’s plans to expand his administration’s first-ever Medicare drug price negotiations could spell big trouble for the pharmacists who support seniors living in long-term care settings, advocates warned in response.
Stay in the Know
Get the latest news and updates on issues impacting the long-term pharmacy community.